GetTopicDetailResponse(id=1ba63e26086, topicName=去甲基化藥物, introduction=去甲基化藥物, content=null, image=null, comments=2, allHits=2032, url=https://h5.medsci.cn/topic?id=37260, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=53553, tagList=[TagDto(tagId=53553, tagName=去甲基化藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2194228, encodeId=e6572194228b0, content=<a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a> <a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a> <a href='/topic/show?id=7b468016366' target=_blank style='color:#2F92EE;'>#老年急性髓系白血病#</a> <a href='/topic/show?id=98ef112469b8' target=_blank style='color:#2F92EE;'>#系統(tǒng)性綜述和薈萃分析#</a>, objectTitle=Eur Rev Med Pharmacol Sci：venetoclax聯合去甲基化藥物治療老年急性髓系白血病的療效和安全性：系統(tǒng)性綜述和薈萃分析, objectType=article, longId=817526, objectId=83c681e5268c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668018121539_4754896.png, objectUrl=/article/show_article.do?id=83c681e5268c, replyNumber=1, likeNumber=97, createdTime=2024-03-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=83c681e5268c, moduleTitle=Eur Rev Med Pharmacol Sci：venetoclax聯合去甲基化藥物治療老年急性髓系白血病的療效和安全性：系統(tǒng)性綜述和薈萃分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83c681e5268c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2092383, encodeId=737420923831f, content=<a href='/topic/show?id=cfd353291f3' target=_blank style='color:#2F92EE;'>#感染#</a>與<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生異常綜合征#</a>、<a href='/topic/show?id=7e301049039f' target=_blank style='color:#2F92EE;'>#慢性骨髓單核細胞白血病#</a>和使用<a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a>治療的<a href='/topic/show?id=51c2104904e1' target=_blank style='color:#2F92EE;'>#急性骨髓白血病#</a>患者預后的相關性，血液系統(tǒng)疾病的治療預防感染十分重要, objectTitle=Ther Adv Hematol：感染與骨髓增生異常綜合征、慢性骨髓單核細胞白血病和使用低甲基化藥物治療的急性骨髓白血病患者預后的相關性, objectType=article, longId=741925, objectId=da82e41925c2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=da82e41925c2, replyNumber=0, likeNumber=136, createdTime=2022-10-07, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da82e41925c2, moduleTitle=Ther Adv Hematol：感染與骨髓增生異常綜合征、慢性骨髓單核細胞白血病和使用低甲基化藥物治療的急性骨髓白血病患者預后的相關性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=da82e41925c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241612, encodeId=e7821241612f6, content=<a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a><a href='/topic/show?id=2d4c4140296' target=_blank style='color:#2F92EE;'>#地西他濱#</a>克服<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌癥#</a>患者對<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治療#</a>產生的耐受作用, objectTitle=J Immunother Cancer：去甲基化藥物地西他濱克服癌癥患者對免疫治療產生的耐受作用, objectType=article, longId=736931, objectId=37c8e36931bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220823/69c0fcd255a847fc96b6272dcaf6730a.jpg, objectUrl=/article/show_article.do?id=37c8e36931bd, replyNumber=0, likeNumber=195, createdTime=2022-08-28, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c8e36931bd, moduleTitle=J Immunother Cancer：去甲基化藥物地西他濱克服癌癥患者對免疫治療產生的耐受作用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=37c8e36931bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
